Costa Rica vs Eastern Mediterranean (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc)
Costa Rica
98.0%
in 2025
Eastern Mediterranean (WHO region)
61.0%
in 2025
Costa Rica rank
11th
Eastern Mediterranean (WHO region) rank
9th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Costa Rica
- Eastern Mediterranean (WHO region)
How they compare
Costa Rica currently reports 98.0% against 61.0% in Eastern Mediterranean (WHO region), a difference of 37.0%.
That makes Costa Rica's figure about 1.6 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Eastern Mediterranean (WHO region) ahead.
Costa Rica ranks 11th and Eastern Mediterranean (WHO region) ranks 9th of 194 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Eastern Mediterranean (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.0% | 2.0% | 22.0% | Costa Rica |
| 2010s | 90.2% | 37.1% | 53.1% | Costa Rica |
| 2020s | 94.8% | 54.7% | 40.2% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Costa Rica or Eastern Mediterranean (WHO region)?
- Costa Rica, at 98.0% against 61.0% in Eastern Mediterranean (WHO region) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Costa Rica and Eastern Mediterranean (WHO region)?
- 37.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Eastern Mediterranean (WHO region)?
- 18 years are reported by both, from 2008 to 2025.
- How do Costa Rica and Eastern Mediterranean (WHO region) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Costa Rica ranks 11th and Eastern Mediterranean (WHO region) ranks 9th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.